
ASCO Breakthrough
Breast Cancer Gene-Expression Signature May Help Predict Recurrence Postradiotherapy
Breast Cancer Gene-Expression Signature May Help Predict Recurrence Postradiotherapy
In a secondary analysis of NRG Oncology/RTOG 9601, men with a PSA of 0.2 to 1.5 ng/mL before salvage radiation had no significant survival benefit from long-term antiandrogen treatment.
Ljungman Laboratory: Early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.
A survey of early career oncologists suggests onsite child care could open scientific meetings to more women attendees. By Reshma Jagsi, MD, DPhil
RadOnc faculty meet to collaborate on Radiation & Cancer Biology research for cancer therapy.
Students inducted into the Lambda Nu National Honor Society for Radiologic and Imaging Sciences
The RadOnc charity bowl Rally in the Alley , was great fun for a great cause.
The Radiation & Cancer Biology Division and Rogel Cancer Center to introduce the SARRP Image-guided micro irradiator for animal studies to the Experimental Irradiation Shared Resource (EISR) in March 2019.
Four-year appointment begins with Pierce becoming president-elect in June 2019
Celebrating a remarkable career with plans for an Endowed Lectureship
Deanna Carr-West and Julie Wietzke debut new survey for the Patient and Family Engagement team.
The Livingston Daily News reports on the opening of the Brighton Center for Specialty Care.
AAPM to honor RadOnc researchers the Farrington Daniels Award for the best paper published in Medical Physics
Lori Pierce, MD, FASTRO, FASCO is honored by ASCO and the Conquer Cancer Foundation
Justin Mikell, PhD to join RadOnc Physics faculty, Anna Laucis, MD, MPhil to focus on Wellness plus Match Day results!
...where a better life is at the ISOCENTER of a 3-field plan to better Fuel, Energy, and Spirit
First system to integrate genomic biomarkers into routine clinical risk groups